Stay updated on Selonsertib for NASH F3 Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selonsertib for NASH F3 Fibrosis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Taoyuan District, Taiwan, 33305 was removed and Taoyuan, Taiwan, 33305 was added in the locations section, changing the named locality while keeping the same postal code. This reflects a naming update to how the site is identified geographically.
    Difference
    0.0%
    Check dated 2026-05-02T09:30:28.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page’s display/version footer was updated from Revision v3.5.2 to Revision v3.5.3, indicating a minor site software release without altering the underlying study record content.
    Difference
    0.0%
    Check dated 2026-04-25T06:14:30.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-18T03:52:55.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added. Several glossary/related items were removed, including Non-alcoholic fatty liver disease, MedlinePlus Genetics, and Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T07:12:10.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added related topics: Nonalcoholic fatty liver disease and MedlinePlus Genetics to the study page.
    Difference
    0.0%
    Check dated 2026-03-13T01:30:12.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-05T19:50:52.000Z thumbnail image

Stay in the know with updates to Selonsertib for NASH F3 Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.